DE3271190D1 - Hydroxy-substituted-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure - Google Patents

Hydroxy-substituted-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure

Info

Publication number
DE3271190D1
DE3271190D1 DE8282401988T DE3271190T DE3271190D1 DE 3271190 D1 DE3271190 D1 DE 3271190D1 DE 8282401988 T DE8282401988 T DE 8282401988T DE 3271190 T DE3271190 T DE 3271190T DE 3271190 D1 DE3271190 D1 DE 3271190D1
Authority
DE
Germany
Prior art keywords
benzothiazolesulfonamide
intraocular pressure
hydroxy
substituted
elevated intraocular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282401988T
Other languages
German (de)
English (en)
Inventor
Otto W Woltersdorf
Stuart R Michelson
John M Sondey
Harvey Schwam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE3271190D1 publication Critical patent/DE3271190D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70—Sulfur atoms
    • C07D277/76—Sulfur atoms attached to a second hetero atom
    • C07D277/80—Sulfur atoms attached to a second hetero atom to a nitrogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8282401988T 1981-11-03 1982-10-27 Hydroxy-substituted-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure Expired DE3271190D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/317,807 US4386098A (en) 1981-11-03 1981-11-03 6-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure

Publications (1)

Publication Number Publication Date
DE3271190D1 true DE3271190D1 (en) 1986-06-19

Family

ID=23235348

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282401988T Expired DE3271190D1 (en) 1981-11-03 1982-10-27 Hydroxy-substituted-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure

Country Status (16)

Country Link
US (1) US4386098A (enExample)
EP (1) EP0079269B1 (enExample)
JP (1) JPS5885877A (enExample)
AT (1) ATE19733T1 (enExample)
AU (1) AU555821B2 (enExample)
CA (1) CA1184119A (enExample)
DE (1) DE3271190D1 (enExample)
DK (1) DK486282A (enExample)
FI (1) FI823720A7 (enExample)
GR (1) GR77056B (enExample)
IE (1) IE54217B1 (enExample)
IL (1) IL67073A0 (enExample)
NO (1) NO823638L (enExample)
NZ (1) NZ202292A (enExample)
PT (1) PT75777B (enExample)
ZA (1) ZA828003B (enExample)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2155331B (en) * 1980-07-09 1988-09-01 Florida University Of Composition for reducing intraocular pressure
US4619939A (en) * 1980-07-09 1986-10-28 University Of Florida Process for reducing intraocular pressure
US4746745A (en) * 1980-07-09 1988-05-24 Maren Thomas H 1,3,4-thiadiazoline-5-sulfonamides
US4454148A (en) * 1982-09-02 1984-06-12 Merck & Co., Inc. 5-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure
US4483864A (en) * 1983-02-04 1984-11-20 University Of Iowa Research Foundation Non-classical topical treatment for glaucoma
US4975449A (en) * 1983-02-04 1990-12-04 University Of Iowa Research Foundation Topical treatment of glaucoma with 2-benzothiazolesulfonamide derivative
US5095026A (en) * 1983-02-04 1992-03-10 University Of Iowa Research Foundation Prodrugs of carbonic anhydrase inhibitors
US4500538A (en) * 1983-03-14 1985-02-19 Merck & Co., Inc. Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
US4456599A (en) * 1983-04-22 1984-06-26 Merck & Co., Inc. Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
US4542152A (en) * 1983-05-23 1985-09-17 Merck & Co., Inc. 5-[Phenylsulfonyl(or sulfinyl)]thiophene-2-sulfonamides for the topical treatment of elevated intraocular pressure
US4510155A (en) * 1983-06-02 1985-04-09 Merck & Co., Inc. 6(or 5)-Hydroxybenzothiazole-2-sulfonamide-O-sulfate salts for the topical treatment of elevated intraocular pressure
US4788192A (en) * 1983-06-20 1988-11-29 Merck & Co., Inc. 2-Sulfamoylbenzo(b)thiophene derivatives pharmaceutical compositions and use
US4585787A (en) * 1983-06-20 1986-04-29 Merck & Co., Inc. 5-[2(Or 3)-hydroxyphenylsulfonyl]thiophene-2-sulfonamides for the topical treatment of elevated intraocular pressure
ES533389A0 (es) * 1983-06-20 1985-10-16 Merck & Co Inc Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida.
US4486444A (en) * 1983-06-20 1984-12-04 Merck & Co., Inc. (Hydroxybenzoyl)thiophenesulfonamide and acyl derivatives thereof for the topical treatment of elevated intraocular pressure
IL72070A (en) * 1983-06-20 1988-11-30 Merck & Co Inc 2-sulfamoylbenzo(b)-thiophene derivatives,their preparation and pharmaceutical compositions containing them
US4622403A (en) * 1983-10-11 1986-11-11 Merck Frosst Canada, Inc. 6-H dibenz[b,f]thiepin compounds
US4505923A (en) * 1983-10-31 1985-03-19 Merck & Co., Inc. Ethers of hydroxybenzothiazole-2-sulfonamide for the topical treatment of elevated intraocular pressure
US4668697A (en) * 1983-10-31 1987-05-26 Merck & Co., Inc. Elevated intraocular pressure lowering benzo-[b]-thiophene-2-sulfonamide derivatives, compositions, and method of use therefor
US4544667A (en) * 1984-02-09 1985-10-01 Merck & Co., Inc. 2-Sulfamoylbenzo[b]furan derivatives for the treatment of elevated intraocular pressure
US4840963A (en) * 1984-03-14 1989-06-20 Merck & Co., Inc. 2-Sulfamoyl-1H-indole derivatives for the treatment of elevated intraocular pressure
DE3576498D1 (de) * 1984-03-14 1990-04-19 Merck & Co Inc 2-sulfamoyl-1h-indole-derivate zur behandlung von hohem intraocularem druck.
IT1176613B (it) * 1984-08-14 1987-08-18 Ravizza Spa Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione
DE3568431D1 (en) * 1984-12-12 1989-04-06 Merck & Co Inc Substituted aromatic sulfonamides, their preparation and ophthalmic compositions containing them
US4863922A (en) * 1984-12-12 1989-09-05 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use
US4929637A (en) * 1985-12-24 1990-05-29 Merck & Co., Inc. Substituted thiophene-2-sulfonamide antiglaucoma agents
US4914111A (en) * 1987-03-23 1990-04-03 Merck & Co., Inc. 4-Benzylthiophene (or furan)-2-sulfonamides as antiglaucoma agents
US4847289A (en) * 1987-06-08 1989-07-11 Merck & Co., Inc. Thiophene sulfonamide antiglaucoma agents
US4929549A (en) * 1989-02-08 1990-05-29 Merck & Co., Inc. 5-carbamoylthieno[2,3-b]thiophene-2-sulfon-amides as topically active carbonic anhydrase inhibitors
US5059613A (en) * 1990-03-19 1991-10-22 Research Corporation Technologies, Inc. Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors
US5091409A (en) * 1990-05-17 1992-02-25 Merck & Co., Inc. 4-alkylamino-6-(C3-5 -hydrocarbyl)thieno[2,3-B]thiopyran-2-sulfonamide-7,7-dioxides
US5216020A (en) * 1990-10-12 1993-06-01 Merck & Co., Inc. Substituted 4,5-dihydrothieno(2,3-b)thiophene-2-sulfonamides and 6,6-dioxides thereof
SG84487A1 (en) 1991-04-17 2001-11-20 Merck & Co Inc Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a b-adrenergic antagonist
US5300499A (en) * 1992-09-02 1994-04-05 Allergan, Inc. 5-substituted 3-thiophene sulfonamides as antiglaucoma agents
US5519040A (en) * 1994-04-29 1996-05-21 Allergan Substituted thiazole sulfonamides as antiglaucoma agents
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
US6316443B1 (en) 1994-08-04 2001-11-13 Merck & Co., Inc. Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a β-adrenergic antagonist
US5789435A (en) * 1995-05-22 1998-08-04 Advanced Research And Technology Institute Method to increase retinal and optical nerve head blood flow velocity in order to preserve sight
US6156785A (en) * 1998-01-23 2000-12-05 Merck Sharp & Dohme B.V. Method for increasing oxygen tension in the optic nerve and retina
EP1251862B1 (en) 2000-01-18 2008-10-01 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
US6548535B2 (en) 2000-01-18 2003-04-15 Merck & Co., Inc. Method for treating ocular hypertension
US20020055458A1 (en) * 2000-08-11 2002-05-09 Einar Stefansson Method for the prevention and treatment of retinopathy
US20040254230A1 (en) * 2001-12-03 2004-12-16 Ogidigben Miller J. Method for treating ocular hypertension
AU2003216547A1 (en) * 2002-03-15 2003-09-29 Merck And Co., Inc. Compositions and methods for treating glaucoma and ocular hypertension
US20060258726A1 (en) * 2002-06-06 2006-11-16 Xavier Billot 1,5-Disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
WO2003105847A1 (en) * 2002-06-14 2003-12-24 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
US20050239787A1 (en) * 2002-06-17 2005-10-27 Goetz Michael A Novel maxi-k channel blockers, methods of use and process for making the same
JP2005532361A (ja) * 2002-06-17 2005-10-27 メルク　エンド　カムパニー　インコーポレーテッド 高眼圧症の治療用の眼科用組成物
EP1515974A4 (en) * 2002-06-17 2007-02-28 Merck & Co Inc NEW MAXI-K CHANNEL BLOCKS, METHOD OF USE AND METHOD FOR THE PRODUCTION THEREOF
WO2004019938A1 (en) * 2002-08-28 2004-03-11 Merck Frosst Canada & Co. Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma
JP2006505572A (ja) * 2002-10-25 2006-02-16 メルク フロスト カナダ アンド カンパニー Ｅｐ４受容体アゴニストとしての２−ピロリドン
CN1791402A (zh) * 2003-03-27 2006-06-21 麦克公司 治疗眼高压的眼科组合物
WO2008140051A1 (ja) * 2007-05-11 2008-11-20 Santen Pharmaceutical Co., Ltd. 非麦角系の選択的ｄ２受容体アゴニストを有効成分として含有する後眼部疾患の予防又は治療剤
US8332007B2 (en) * 2009-01-12 2012-12-11 The Board Of Trustees Of The University Of Illinois Quantitative three-dimensional mapping of oxygen tension

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2595334A (en) * 1950-04-08 1952-05-06 American Cyanamid Co Benzothiazolesulfonamides and method of preparing the same
US3519630A (en) * 1969-02-06 1970-07-07 Pennsalt Chemicals Corp Antibacterial and antifungal treatment with sulfones
DE3068986D1 (en) * 1980-01-28 1984-09-27 Merck & Co Inc Ophthalmic inserts for lowering intraocular pressure comprising carbonic anhydrase inhibitors

Also Published As

Publication number Publication date
FI823720A0 (fi) 1982-11-01
DK486282A (da) 1983-05-04
GR77056B (enExample) 1984-09-05
FI823720L (fi) 1983-05-04
ATE19733T1 (de) 1986-05-15
EP0079269B1 (en) 1986-05-14
JPS5885877A (ja) 1983-05-23
US4386098A (en) 1983-05-31
IE54217B1 (en) 1989-07-19
PT75777A (en) 1982-12-01
NZ202292A (en) 1986-01-24
FI823720A7 (fi) 1983-05-04
PT75777B (en) 1986-01-15
NO823638L (no) 1983-05-04
IL67073A0 (en) 1983-02-23
IE822618L (en) 1983-05-03
AU9004882A (en) 1983-05-12
AU555821B2 (en) 1986-10-09
CA1184119A (en) 1985-03-19
ZA828003B (en) 1984-07-25
EP0079269A1 (en) 1983-05-18

Similar Documents

Publication Publication Date Title
DE3271190D1 (en) Hydroxy-substituted-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure
DE3364150D1 (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
PH23978A (en) Process for the preparation of glycerophosphocholine and glycerophosphoethanolamine derivatives
PH21102A (en) Improvements in or relating to benzothiophene derivatives as antiastmatic agents
AU551719B2 (en) Anthralin compositions for treatment of skin diseases
PT75229B (en) Process for preparing benzothiszolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
AU550675B2 (en) Pharmaceutical compositions for the treatment of skin
EP0122831A3 (en) Benzothiazole-2-sulfonamide derivatives for the topical treatment of elevated intraocular pressure
DE3570076D1 (en) 2-sulfamoylbenzoûb¨furan derivatives and ophtalmic composition for the treatment of elevated intraocular pressure
EP0073251A4 (en) RESPIRATORY ORGAN DISEASE TREATMENT AGENT.
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
DE3373978D1 (en) Composition for the care or treatment of the human skin
EP0122178A3 (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
ZA842959B (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
ZA848451B (en) Ethers of hydroxybenzothiazole-2-sulfonamide for the topical treatment of elevated intraocular pressure
ZA842665B (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
ZA842958B (en) Benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure
ZA824941B (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
EP0155214A3 (en) 2-sulfamoyl-1h-indole derivatives for the treatment of elevated intraocular pressure
ZA844114B (en) 6(or 5)-hydroxybenzothiazole-2-sulfonamide-o-sulfate salts for the topical treatment of elevated intraocular pressure
AU1966988A (en) Ophthalmic agent and related compositions and method for treatment of the cornea
SU1238290A1 (ru) Способ получения препарата для лечения желудочно-кишечных заболеваний
FI842101A7 (fi) Farmaseuttinen silmälääkekoostumus kohonneen silmänsisäisen paineen paikalliseen käsittelyyn.
GB2083747B (en) Treatment of ocular hypertension
JO1104B1 (en) Preparations for the treatment and use of celaria

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee